SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-117134
Filing Date
2022-11-10
Accepted
2022-11-10 16:11:40
Documents
16
Period of Report
2022-11-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2230104d2_8k.htm   iXBRL 8-K 28283
2 EXHIBIT 5.1 tm2230104d2_ex5-1.htm EX-5.1 9877
6 GRAPHIC tm2230104d2_ex5-1img001.jpg GRAPHIC 2750
7 GRAPHIC tm2230104d2_ex5-1img002.jpg GRAPHIC 2975
8 GRAPHIC tm2230104d2_ex5-1img003.jpg GRAPHIC 12416
  Complete submission text file 0001104659-22-117134.txt   240075

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA atxs-20221110.xsd EX-101.SCH 3036
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxs-20221110_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxs-20221110_pre.xml EX-101.PRE 22597
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2230104d2_8k_htm.xml XML 3603
Mailing Address 75 STATE STREET SUITE 1400 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 1400 BOSTON MA 02109 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37467 | Film No.: 221377269
SIC: 2834 Pharmaceutical Preparations